China urged all parties involved in the Ukraine war to “remain calm and exercise restraint” this Wednesday (11/20/2024) after Russia approved a new nuclear doctrine.
Chinese Foreign Ministry spokesman Lin Jian said at a press conference today that it was necessary to “promote dialogue and consultation to ease tensions and reduce strategic risks.”
Furthermore, he reiterated the Asian giant’s “consistent and clear” position regarding the Ukrainian conflict, advocating “de-escalation and a political solution”.
Lin stressed that China will continue to play a constructive role in resolving the crisis and stressed the importance of reducing tensions through dialogue and diplomacy.
Last September, the Chinese Foreign Ministry had already stressed that “nuclear weapons should not be used” and “nuclear war should not be fought.”
Then, the ministry reminded that in January 2022, the leaders of five nuclear-armed countries, including the United States, Russia and China, issued a joint statement in which they said that “a nuclear war cannot be won and should not be fought.” Needed. “
Yesterday, on Tuesday, Russian President Vladimir Putin approved a nuclear doctrine that allows responding with nuclear weapons to conventional attacks that threaten the sovereignty of Russia and Belarus.
This announcement came on the same day when the Russian Defense Ministry confirmed the first Ukrainian attack with American-made ATACMS ballistic missiles against a military installation on the territory of this country.
CP (EFE, AFP)
Just yesterday, the hare came with news that surprised us all: Sony Group Corporation was…
Malaga.- Since taking over as Davis Cup Captain in December 2022 David Ferrer I have…
This case is decorated with a de longs mois chronic pendant. Indeed, two long-time partners…
Sabertooths hunted large herbivores in the savannas and open grasslands/Paleoalbarca/WikipediaMore than 11,000 years ago there…
Wednesday, November 20, 2024 at 1:20 p.m. Last year, the Ministry of Health identified 107…
Brookfield takeover proposal by the Grifols family The delisting of the Catalan pharmaceutical company from…